Clinical Trials in Texas

Showing 10261-10280 of 15,101 trials

Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)

NCT02773693

The primary objective of the current study is to determine if providing cognitive-behavioral therapy of Insomnia and nightmares (CBTin) and Cognitive Processing Therapy of PTSD (CPT) results in greater PTSD and sleep symptom reduction than CPT only. A secondary objective is to determine if the sequencing of CBTl\&N before or after CPT results in differential effects on PTSD and sleep symptom reduction.

TraumaInsomniaNightmares

University of North Texas, Denton, TX94 participantsStarted Aug 2016

Fort Hood, Texas, United States

TERMINATED55 miles

Post-Market Study of the Modular Revision Hip System

NCT01464645

The purpose of this study is to examine the short term efficacy of the MRH system as well as determine if operating room time is decreased using this simple, two-tray system.

Aseptic LooseningOsteolysisTraumatic Fracture+1 more

Encore Medical, L.P.16 participantsStarted Jan 2012

Burbank, California, United States • Redwood City, California, United States • Syracuse, New York, United States +3 more locations

COMPLETEDPhase 355 miles

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

NCT01262365

The primary objective of the study is to confirm the clinical efficacy of epratuzumab in the treatment of subjects with Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

UCB Pharma793 participantsStarted Dec 2010

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Escondido, California, United States +138 more locations

Treatment of Comorbid Sleep Disorders and Post Traumatic Stress Disorder (PTSD)

Post-Market Study of the Modular Revision Hip System

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus

Find Trials by Condition in Texas

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Optimizing Vitamin D Status During Initial Military Training

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Medical Therapy of Prostatic Symptoms

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Evaluation of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease

Multicenter Continuous Peripheral Nerve Block Surveillance Study

A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation

Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer

Sevelamer for Reducing Endotoxemia and Immune Activation

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

A Study of Axitinib in Advanced Carcinoid Tumors

PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis